Company intelligence / Profile preview
Histocell
Bilbao area / Parque Tecnológico Zamudio, Bizkaia/Basque Country, Spainhistocell.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Histocell’s lead cell therapy candidate HC016 is undergoing clinical trials for the treatment of acute respiratory distress syndrome—including COVID‑19 patients—and acute spinal cord injury. The company also markets medical devices for wound care and has a strong IP portfolio with over 50 patents. Around 300 patients have been treated with ATMPs manufactured by Histocell to date.
- Therapeutic areas
- DermatologyPulmonologyNeurology
- Modalities
- Cell therapyExosome-based therapySecretome-based therapyMedical device (for wound healing, dermo-cosmetics)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Reprocell (GMP iPSC & MSC manufacturing partnership)Other CDMO clients not individually listed but includes European, US, Japanese customers
Beyond the preview
Go deeper on Histocell.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Histocell.